US Federal 2023-2024 Regular Session

US Federal House Bill HB1986

Introduced
3/29/23  
Refer
3/29/23  

Caption

To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases for fiscal year 2024.

Impact

If enacted, HB1986 will specifically constrain the financial resources allocated to research and initiatives concerning arthritis and musculoskeletal disorders. This funding limitation could potentially impact ongoing studies, development of new treatment methodologies, and overall patient care associated with these diseases. Stakeholders in the health field may express concerns about the long-term effects of reduced funding on public health outcomes, particularly for those suffering from chronic pain and mobility issues.

Summary

House Bill 1986 seeks to impose a funding limitation for the Department of Health and Human Services, specifically targeting the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the fiscal year 2024. The bill stipulates that the total amounts authorized to be appropriated or otherwise available for the aforementioned department are not to exceed $605,065,000. This legislative measure underscores a broader effort to control federal spending and address budgetary concerns within health-related agencies.

Contention

The bill may lead to significant debate, particularly among healthcare advocates and legislators with vested interests in health and research funding. Critics may argue that reducing available funds for crucial health services will hinder advancements in medical research, especially in a field that already struggles with sufficient funding. Proponents, however, may assert that stringent budget measures are necessary to ensure fiscal responsibility and to prioritize the allocation of resources in accordance with broader economic strategies.

Companion Bills

No companion bills found.

Previously Filed As

US HR1079

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

US SJR4

Research and education: federal funding cuts: the National Institutes of Health and postsecondary educational institutions.

US HB235

Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.

US HB73

No Pro-Abortion Task Force Act This bill prohibits federal funding of the Reproductive Healthcare Access Task Force. The Department of Health and Human Services launched the task force on January 21, 2022, to identify and coordinate departmental activities related to accessing sexual and reproductive health care.

US HB229

World Deserves To Know Act This bill requires sanctions on certain members of the Chinese Communist Party (CCP) and officials of Chinese health agencies. It also addresses related issues. The President must impose visa- and property-blocking sanctions on any foreign person who is a CCP official and who is knowingly responsible for or complicit in (1) the disappearances of whistleblowers and citizen journalists in China relating to COVID-19, or (2) limiting free speech and academic freedom in China relating to COVID-19. The President must also impose such sanctions on specified individuals who have leadership positions in China's Center for Disease Control and Prevention and China's National Health Commission (NHC). The authority to impose such sanctions shall end when the President certifies to Congress that an independent and unimpeded investigation into the potential origin of COVID-19 from the Wuhan Institute of Virology has taken place. The bill also bars federal funds and certain federal student assistance from going to institutions of higher education that enter into a contract with any element or China-based affiliate of the NHC. Federal funding to the National Academy of Sciences may not be used to enter into a contract with any element or China-based affiliate of the NHC. The Government Accountability Office must report to Congress a review of all funds that the National Institutes of Health have made available to the NHC since FY2010. This report must also be publicly available.

US HJM6

Urging Congress to ensure strong annual federal funding for the National Institutes of Health and to increase investment in cutting-edge medical research through grants from the NIH to research institutions.

US HB85

This bill grants exclusive jurisdiction to the U.S. District Court for the District of Columbia over (1) cases arising under immigration laws, or (2) claims by foreign nationals challenging an order of removal or another action authorized under the Immigration and Nationality Act.

US HB70

Freedom for Farmers Act of 2023 This bill abolishes the Agency for Toxic Substances and Disease Registry. This agency, which is part of the Department of Health and Human Services (HHS), investigates and responds to environmental exposures to hazardous substances in communities. HHS must transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.

US SP0784

JOINT RESOLUTION RECOGNIZING MAY 2025 AS NATIONAL ARTHRITIS AWARENESS MONTH

US HB8559

To amend the National Defense Authorization Act for Fiscal Year 2021 to prohibit certain institutions of higher education from receiving research and development awards, and for other purposes.

Similar Bills

No similar bills found.